Kang SM - Search Results

1

Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines.

Lee YN, Kim MC, Lee YT, Kim YJ, Kang SM. Lee YN, et al. Among authors: kang sm. Immune Netw. 2015 Oct;15(5):213-21. doi: 10.4110/in.2015.15.5.213. Epub 2015 Oct 26. Immune Netw. 2015. PMID: 26557805 Free PMC article. Review.

2

Influenza virus-like particles containing M2 induce broadly cross protective immunity.

Song JM, Wang BZ, Park KM, Van Rooijen N, Quan FS, Kim MC, Jin HT, Pekosz A, Compans RW, Kang SM. Song JM, et al. Among authors: kang sm. PLoS One. 2011 Jan 18;6(1):e14538. doi: 10.1371/journal.pone.0014538. PLoS One. 2011. PMID: 21267073 Free PMC article.

3

H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals.

Lee DH, Park JK, Lee YN, Song JM, Kang SM, Lee JB, Park SY, Choi IS, Song CS. Lee DH, et al. Among authors: kang sm. Vaccine. 2011 May 23;29(23):4003-7. doi: 10.1016/j.vaccine.2011.03.067. Epub 2011 Apr 2. Vaccine. 2011. PMID: 21463681 Free PMC article.

4

Immunogenicity of low-pH treated whole viral influenza vaccine.

Quan FS, Li ZN, Kim MC, Yang D, Compans RW, Steinhauer DA, Kang SM. Quan FS, et al. Among authors: kang sm. Virology. 2011 Aug 15;417(1):196-202. doi: 10.1016/j.virol.2011.05.014. Epub 2011 Jun 30. Virology. 2011. PMID: 21722934 Free PMC article.

5

MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination.

Kang SM, Yoo DG, Kim MC, Song JM, Park MK, O E, Quan FS, Akira S, Compans RW. Kang SM, et al. J Virol. 2011 Nov;85(21):11391-400. doi: 10.1128/JVI.00080-11. Epub 2011 Aug 24. J Virol. 2011. PMID: 21865389 Free PMC article.

6

Novel vaccines against influenza viruses.

Kang SM, Song JM, Compans RW. Kang SM, et al. Virus Res. 2011 Dec;162(1-2):31-8. doi: 10.1016/j.virusres.2011.09.037. Epub 2011 Oct 1. Virus Res. 2011. PMID: 21968298 Free PMC article. Review.

7

Protective effect of ginseng polysaccharides on influenza viral infection.

Yoo DG, Kim MC, Park MK, Park KM, Quan FS, Song JM, Wee JJ, Wang BZ, Cho YK, Compans RW, Kang SM. Yoo DG, et al. Among authors: kang sm. PLoS One. 2012;7(3):e33678. doi: 10.1371/journal.pone.0033678. Epub 2012 Mar 19. PLoS One. 2012. PMID: 22442708 Free PMC article.

8

Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.

Quan FS, Kim MC, Lee BJ, Song JM, Compans RW, Kang SM. Quan FS, et al. Among authors: kang sm. Virology. 2012 Sep 1;430(2):127-35. doi: 10.1016/j.virol.2012.05.006. Epub 2012 Jun 2. Virology. 2012. PMID: 22658901 Free PMC article.

9

Microneedle and mucosal delivery of influenza vaccines.

Kang SM, Song JM, Kim YC. Kang SM, et al. Expert Rev Vaccines. 2012 May;11(5):547-60. doi: 10.1586/erv.12.25. Expert Rev Vaccines. 2012. PMID: 22697052 Free PMC article. Review.

10

Immunogenicity and protection of oral influenza vaccines formulated into microparticles.

Shastri PN, Kim MC, Quan FS, D'Souza MJ, Kang SM. Shastri PN, et al. Among authors: kang sm. J Pharm Sci. 2012 Oct;101(10):3623-35. doi: 10.1002/jps.23220. Epub 2012 Jun 18. J Pharm Sci. 2012. PMID: 22711602 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,452 results

Search Page